2-166039437-G-A
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM5PP2PP3_StrongPP5_Very_Strong
The NM_001165963.4(SCN1A):c.2575C>T(p.Arg859Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R859H) has been classified as Pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.2575C>T | p.Arg859Cys | missense_variant | Exon 17 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.2575C>T | p.Arg859Cys | missense_variant | Exon 16 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.2542C>T | p.Arg848Cys | missense_variant | Exon 14 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.2 | c.2491C>T | p.Arg831Cys | missense_variant | Exon 16 of 28 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149732Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000137 AC: 2AN: 1459694Hom.: 0 Cov.: 36 AF XY: 0.00000138 AC XY: 1AN XY: 726182 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000668 AC: 1AN: 149732Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 72854 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
Generalized epilepsy with febrile seizures plus, type 2 Pathogenic:3
The variant is not observed in the gnomAD v2.1.1 dataset. The variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.96; 3Cnet: 1.00). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000068592 / PMID: 16525050). Different missense changes at the same codon (p.Arg859His, p.Arg859Pro) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000093639 / PMID: 21864321, 29141311). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
- -
Developmental and epileptic encephalopathy Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 859 of the SCN1A protein (p.Arg859Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Dravet syndrome or generalized epilepsy with febrile seizures (PMID: 16525050, 18930999). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 68592). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SCN1A function (PMID: 16525050, 25576396). This variant disrupts the p.Arg859 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21864321, 24277604, 28084635; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate reduced neuronal excitability (PMID: 16525050); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25576396, 20831750, 20100831, 17304347, 25754450, 19292758, 35074891, 32090326, 18930999, 16525050) -
Severe myoclonic epilepsy in infancy Pathogenic:1
- -
Seizure Pathogenic:1
de novo, absent from gnomAD, already known pathogenic. -
Generalized epilepsy with febrile seizures plus, type 1 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at